Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
239.37
+1.52 (0.64%)
Nov 21, 2024, 11:53 AM EST - Market open

Company Description

Labcorp Holdings Inc. provides laboratory services.

It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs).

In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing.

It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.

The company was founded in 1995 is headquartered in Burlington, North Carolina.

Labcorp Holdings Inc.
Labcorp Holdings logo
Country United States
Founded 1971
Industry Diagnostics & Research
Sector Healthcare
Employees 67,000
CEO Adam Schechter

Contact Details

Address:
358 South Main Street
Burlington, North Carolina 27215
United States
Phone 336 229 1127
Website labcorp.com

Stock Details

Ticker Symbol LH
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000920148
CUSIP Number 50540R409
ISIN Number US50540R4092
Employer ID 99-2588107
SIC Code 8071

Key Executives

Name Position
Adam H. Schechter President, Chief Executive Officer and Chairman
Glenn A. Eisenberg Chief Financial Officer and Executive Vice President
Mark S. Schroeder Executive Vice President, President of Diagnostics Laboratories and Chief Operating Officer
Dr. Brian J. Caveney J.D., M.D., M.P.H. EVice President, President of Early Development Research Laboratories and Chief Medical and Scientific Officer
Anita Z. Graham Executive Vice President and Chief Human Resources Officer
Peter J. Wilkinson Senior Vice President and Chief Accounting Officer
Akinbolade Oyegunwa Executive Vice President and Chief Information and Technology Officer
Christin O'Donnell Vice President of Investor Relations
Sandra D. van der Vaart J.D. Executive Vice President, Chief Legal Officer and Corporate Secretary
Amy B. Summy Executive Vice President and Chief Marketing Officer

Latest SEC Filings

Date Type Title
Nov 19, 2024 8-K Current Report
Nov 12, 2024 144 Filing
Oct 29, 2024 10-Q Quarterly Report
Oct 24, 2024 144 Filing
Oct 24, 2024 8-K Current Report
Oct 18, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 10, 2024 8-K Current Report
Sep 24, 2024 8-K Current Report
Sep 23, 2024 8-K Current Report
Sep 18, 2024 8-K Current Report